Clinical update: new drugs for HIV/AIDS.
Monotherapy to treat the human immunodeficiency virus (HIV) is now a thing of the past. Combination drug therapies and several new anti-HIV drugs in clinical trials offer new promise for slowing the progress and deleterious effects of this disease.
Mount Sinai Medical Center, Miami Beach, FL, USA.
S
S
Gracia Jones
T H
TH
Baggett
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000451:nursing; D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000480:Alkynes; D019380:Anti-HIV Agents / Q000737:chemistry / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D048588:Benzoxazines; D002219:Carbamates; D002626:Chemistry, Pharmaceutical; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D017277:Drug Approval; D005663:Furans; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D063065:Organophosphonates; D010078:Oxazines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D000099227:Abacavir
D000225:Adenine; D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D002219:Carbamates; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D005663:Furans; D017320:HIV Protease Inhibitors; D063065:Organophosphonates; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir; C098320:efavirenz; C106812:adefovir dipivoxil